Antibody-Targeted NK Cell Activation for Cancer Therapy
$400,582R01FY2004CANIH
Fox Chase Cancer Center, Philadelphia PA
Investigators
Linked publications & trials
Paper 38196606Paper 37878417Paper 34763586Paper 34737215Paper 33509790Paper 33379189Paper 32878910Paper 32833941Paper 32601975Paper 32178823Paper 31866479Paper 30563830Paper 29250574Paper 29043413Paper 28770278Paper 28651964Paper 27924752Paper 27546622Paper 27375028Paper 26421752Paper 26352774Paper 26165839Paper 25911943Paper 25873172Paper 25707963Paper 25300860Paper 25265912Paper 25204776Paper 24662823Paper 24652987Paper 24400111Paper 24312117Paper 23993387Paper 23125191Paper 22424219Paper 22245472Paper 21969811Paper 21842208Paper 21785464Paper 21677677Paper 21406401Paper 20858866Paper 20414205Paper 20332297Paper 19304016Paper 18565858Paper 18424763Paper 18223225Paper 17709495Paper 17457220Paper 16365595Paper 15471859Paper 11342630Paper 11156528
View original record on NIH RePORTER →